Sucralfate NDC 81033-149

NDC codes

FDA NDC Directory

Product NDC (as listed)81033-149Labeler and product segments. Claims need a package NDC.

Product NDC at billing width81033-0149Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
81033-149-44	81033014944	40 CUP, UNIT-DOSE in 1 CARTON (81033-149-44) / 10 mL in 1 CUP, UNIT-DOSE (81033-149-10)Marketed from Jul 1, 2024
81033-149-52	81033014952	100 CUP, UNIT-DOSE in 1 CASE (81033-149-52) / 10 mL in 1 CUP, UNIT-DOSE (81033-149-10)Marketed from Jul 1, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sucralfate
Generic name (nonproprietary): sucralfate
Active ingredients: Sucralfate — 1 g/10mL
Dosage form: Suspension
Route: Oral
Labeler: Kesin Pharma Corporation
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216474
Marketing start: Jul 1, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Organometallic Compounds (Chemical structure)
Identifiers: Product ID 81033-149_36d940f2-207c-68c5-e063-6294a90a6b4aSPL ID 36d940f2-207c-68c5-e063-6294a90a6b4aSPL set ID 36d940f2-207b-68c5-e063-6294a90a6b4aRxCUI 313123UNII XX73205DH5
Pharmacologic class: Aluminum Complex

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N481033014944 followed by a unit qualifier and the quantity

Package 81033-0149-44. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 1, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Sucralfate Oral Suspension is indicated in the short-term (up to 8 weeks) treatment of active duodenal ulcer.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 216474

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 216474
Product	Strength	Form · route	Labeler	Product NDC
sucralfate	Sucralfate 1 g/10mL	SuspensionOral	Bryant Ranch Prepack	72162-2479
sucralfate	Sucralfate 1 g/10mL	SuspensionOral	Strides Pharma Science Limited	64380-149